Search
Close this search box.
Day: December 6, 2021

Anaqua and ASU Co., Ltd. Announce Strategic Partnership

Long-term partnership to provide Anaqua intellectual property management systems migration and support for clients in Japan TOKYO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property management solutions, and ASU Co., Ltd. (ASU), one

Read More

Helsinn Achieves Carbon Neutrality

Helsinn Achieves Carbon Neutrality Lugano, Switzerland, December 6, 2021 – Helsinn Group (“Helsinn”), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, today announces that it has achieved carbon neutrality for the first time. Since 2012, Helsinn

Read More

Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12

First and only neutralizing antibody therapy for this age group SHANGHAI, China, Dec. 06, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced

Read More